Abrinica, Clyde .

HRN: 27-22-75  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/08/2025
CLARITHROMYCIN 125MG/5ML, 60ML SUSPENSION (BOT)
09/08/2025
09/14/2025
ORAL
2.5ml
Q12H
PCAP D
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines